Related Experiment Video
Updated: Apr 11, 2026
04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
1.3K
Antihypertensive therapy causes erectile dysfunction
1University of Oklahoma College of Medicine, Oklahoma City, Oklahoma, USA.
Current Opinion in Cardiology
|June 8, 2015
Summary
Erectile dysfunction is linked to comorbid conditions like hypertension and diabetes, and certain medications. Early screening and tailored treatment, including phosphodiesterase 5 inhibitors when appropriate, are crucial for managing this common male sexual disorder.
Area of Science:
- Cardiovascular Medicine
- Urology
- Pharmacology
Background:
- Erectile dysfunction (ED) affects 40% of men in the US, with complex and multifactorial causes.
- The pathophysiologic mechanisms underlying ED are not fully understood.
- ED is frequently associated with several comorbid conditions.
Purpose of the Study:
- To review the multifactorial causes of erectile dysfunction.
- To highlight the role of comorbid conditions and medications in ED development.
- To guide appropriate screening and treatment strategies for ED.
Main Methods:
- Review of recent studies on erectile dysfunction.
- Analysis of the relationship between comorbid conditions and ED.
- Evaluation of the impact of cardiovascular and antihypertensive drugs on ED.
Main Results:
- ED is associated with hypertension, coronary artery disease (CAD), heart failure, and diabetes mellitus.
- Thiazide diuretics, aldosterone receptor blockers, and β-adrenergic receptor blockers are implicated in ED.
- Patient awareness of drug effects can exacerbate ED (Hawthorne effect).
Conclusions:
- Physicians must screen for ED, considering associated comorbidities and treatments.
- Tailored treatment regimens are essential for managing ED.
- Phosphodiesterase 5 inhibitors are recommended, with strict contraindication in patients on organic nitrates due to CAD.
Related Concept Videos
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
764
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
764
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
568
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
568
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.5K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.5K
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
889
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
889
01:16Antihypertensive Drugs: Action of Diuretics
2.8K
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.8K
01:23Antihypertensive Drugs: Vasodilators
2.5K
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.5K